SEHK:2142Biotechs
HBM Holdings (SEHK:2142) Teams Up With Lonza, Is The Stock Already Fully Valued?
Nona Biosciences, part of HBM Holdings (SEHK:2142), has entered a collaboration with Lonza to co-develop single domain antibody blood brain barrier crossing technology for central nervous system diseases, drawing fresh attention to HBM Holdings stock.
See our latest analysis for HBM Holdings.
The Lonza partnership has arrived at a time when HBM Holdings’ share price has gained 5.47% in the last day and 13.12% over the past week, yet remains down 21.35% over 90 days. Meanwhile, the 1 year...